Nano-X Imaging Ltd. (NNOX): Shareholders' Equity

Annual figures by period end, from SEC filings.

$139.73M
As of 2025-12-31
-13.6%
3-year compound annual growth
-9.5%
5-year compound annual growth
$292.15M2018-12-31: -$6.38M2019-12-31: -$8.78M2020-12-31: $230.75M2021-12-31: $292.15M2022-12-31: $216.68M2023-12-31: $195.51M2024-12-31: $189.12M2025-12-31: $139.73M$139.73M
2018-12-31 Shareholders' Equity (USD) 2025-12-31
Period endedShareholders' EquityChange YoYSource filing
2025-12-31$139.73M-26.1%2026-04-30, Balance as of period end
2024-12-31$189.12M-3.3%2026-04-30, Balance as of period end
2023-12-31$195.51M-9.8%2026-04-30, Balance as of period end
2022-12-31$216.68M-25.8%2025-04-09, Balance as of period end
2021-12-31$292.15M+26.6%2024-04-22, Balance as of period end
2020-12-31$230.75Mn/m2023-05-01, Balance as of period end
2019-12-31-$8.78Mn/m2022-05-02, Balance as of period end
2018-12-31-$6.38Mn/a2021-04-06, Balance as of period end

Shareholders' Equity at similar companies

Companies with the same SEC industry code (X-Ray Apparatus & Tubes & Related Irradiation Apparatus), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedShareholders' EquityChange YoY
Nano-X Imaging Ltd. (NNOX)2025-12-31$139.73M-26.1%
CapsoVision, Inc (CV)2025-12-31$13.26Mn/m
Hyperfine, Inc. (HYPR)2025-12-31$41.01M-16.4%
Escalon Medical Corp (ESMC)2025-06-30$1.92M+5.8%
LogicMark, Inc. (LGMK)2025-12-31$16.28M+56.8%
Nexgel, Inc. (NXGL)2025-12-31$4.46M-22.5%
Allurion Technologies, Inc. (ALUR)2025-12-31-$77.19Mn/m
Biotricity Inc. (BTCY)2026-03-31-$34.68Mn/m
Profound Medical Corp. (PROF)2025-12-31$66.43M+10.0%

Compare NNOX, CV, HYPR, ESMC side by side · Screen every company in X-Ray Apparatus & Tubes & Related Irradiation Apparatus ↗